Enfortumab Vedotin in combination with Pembrolizumab in Urothelial Cancer

Ettinger, S. and Mayer-Ferbas, J. and Jeindl, R. (2025): Enfortumab Vedotin in combination with Pembrolizumab in Urothelial Cancer. Rapid Review Nr.: 019.

[thumbnail of HTA-Informationsdienst_Rapid Review_019.pdf]

Preview

PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
4MB

Item Type:	HTA Information Service
Subjects:	QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology QZ Pathology > QZ 200-380 Neoplasms.Cysts WB Practice of medicine > WB 300-962 Therapeutics WJ Urogenital system > WJ 400-600 Ureter. Bladder. Urethra
Language:	English
Series Name:	Rapid Review Nr.: 019
Deposited on:	03 Nov 2025 14:26
Last Modified:	04 Nov 2025 10:00

Repository Staff Only: item control page